China National Medical Products Administration grants approval of Roche’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer

    NEXT STORY
    Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research
    PREV STORY
    Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Announces U.S. FDA Acceptance and Grant of Priority Review for its New Drug Application of Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma

    author_avatar
    NASDAQ Market News

    Global Telepresence Robot Market 2018-2023 by Component (Head and Body) & Application (Education, Healthcare, Enterprise, and Homecare)

    Dublin, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The "Telepresence Robot Market by Component (Head ...

    author_avatar
    NASDAQ Market News

    2017 Family Health Fair in St. Louis on August 19th

    St. Louis, MO, July 27, 2017 (GLOBE NEWSWIRE) -- St. Louis, MO July 26, ...

    author_avatar
    NASDAQ Market News